D.A. Davidson & Co. Vista Gen Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.14 - $1.07 $6,650 - $50,825	-47,500 Reduced 41.67%	66,500 $10,000
Q2 2022 Jul 28, 2022	SELL	$0.88 - $1.73 $11,880 - $23,355	-13,500 Reduced 10.59%	114,000 $100,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $10,480 - $13,800	-4,000 Reduced 3.04%	127,500 $349,000
Q2 2021 Aug 10, 2021	SELL	$1.96 - $3.15 $3,920 - $6,300	-2,000 Reduced 1.5%	131,500 $414,000
Q1 2021 May 07, 2021	SELL	$1.89 - $2.96 $7,560 - $11,840	-4,000 Reduced 2.91%	133,500 $284,000

Q3 2020 Nov 02, 2020	SELL	$0.48 - $1.03 $12,720 - $27,295	-26,500 Reduced 16.16%	137,500 $96,000
Q2 2020 Aug 10, 2020	BUY	$0.37 - $0.61 $19,980 - $32,940	54,000 Added 49.09%	164,000 $86,000
Q4 2019 Feb 14, 2020	BUY	$0.3 - $1.41 $1,500 - $7,050	5,000 Added 4.76%	110,000 $76,000
Q3 2019 Nov 05, 2019	BUY	$0.46 - $1.29 $10,350 - $29,025	22,500 Added 27.27%	105,000 $112,000
Q2 2019 Aug 13, 2019	SELL	$0.54 - $1.33 $17,280 - $42,560	-32,000 Reduced 27.95%	82,500 $60,000
Q1 2019 May 13, 2019	BUY	$1.1 - $1.76 $22,550 - $36,080	20,500 Added 21.81%	114,500 $147,000
Q4 2018 Jan 29, 2019	BUY	$1.28 - $2.24 $22,400 - $39,200	17,500 Added 22.88%	94,000 $141,000
Q2 2018 Aug 02, 2018	BUY	$0.85 - $1.5 $19,550 - $34,500	23,000 Added 42.99%	76,500 $105,000
Q1 2018 May 04, 2018	SELL	$0.91 - $1.73 $40,950 - $77,850	-45,000 Reduced 45.69%	53,500 $50,000
Q2 2017 Aug 11, 2017	BUY	N/A	98,500	98,500 $0

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.